Guanethidine ophthalmic solution 5 per cent. Use in the treatment of endocrine exophthalmos.
D000328:Adult; D001763:Blepharoptosis / Q000188:drug therapy; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D003228:Conjunctiva / Q000098:blood supply; D004106:Dilatation; D005094:Exophthalmos / Q000188:drug therapy*; D005260:Female; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007634:Keratitis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D010919:Placebos; D011674:Pulse; D012590:Sclera / Q000098:blood supply; D014680:Veins
D009883:Ophthalmic Solutions; D010919:Placebos; D006145:Guanethidine